Novel CAR-T therapy achieves positive results in a high proportion of patients with a refractory type of lymphoma
Dr. Javier Briones, researcher at Sant Pau Research Institute (IR Sant Pau) and Josep Carreras Leukemia Research Institute. Credit: Josep ...